Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS

National Hospital Organization Higashinagoya National Hospital, Nagoya

National Hospital Organization Chibahigashi National Hospital, Chiba

Fukushima Medical University Hospital, Fukushima

Kagawa University Hospital, Kita-gun

Kitasato University Hospital, Sagamihara-shi

Yokohama City University Hospital, Yokohama

National Hospital Organization Kumamoto Saishun Medical Center, Kōshi

National Hospital Organization Osaka Toneyama Medical Center, Toyonaka-shi

Shiga University of Medical Science Hospital, Ōtsu

Tokyo Metropolitan Neurological Hospital, Fuchu-shi

National Epilepsy Center NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka